(Q42512265)

1 November 2017

title

Prevalence of insulin resistance and prediction of glucose intolerance and type 2 diabetes mellitus in women with polycystic ovary syndrome (English)

1 reference

polycystic ovary syndrome

1 November 2017

0 references

0 references

1 reference

0 references

1 reference

1 reference

1 reference

6

1 reference

1 November 2017

Martin Hill

4

0 references

author name string

Jana Vrbikova

1

1 reference

1 November 2017

Katerina Dvorakova

2

1 reference

1 November 2017

Tereza Grimmichova

3

1 reference

1 November 2017

Sona Stanicka

5

1 reference

1 November 2017

Bela Bendlova

7

1 reference

1 November 2017

Luboslav Starka

8

1 reference

1 November 2017

Karel Vondra

9

1 reference

1 November 2017

publication date

1 January 2007

1 reference

Clinical Chemistry and Laboratory Medicine

1 November 2017

published in

1 reference

1 November 2017

volume

45

1 reference

1 November 2017

issue

5

1 reference

1 November 2017

page(s)

639-644

1 reference

Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis

1 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.113

Detecting insulin resistance in polycystic ovary syndrome: purposes and pitfalls.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.113

Prevalence of type 2 diabetes mellitus and impaired glucose tolerance in Asian women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.113

Cardiovascular risk factors in young Czech females with polycystic ovary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.113

Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.113

Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.113

Increased risk of non-insulin dependent diabetes mellitus, arterial hypertension and coronary artery disease in perimenopausal women with a history of the polycystic ovary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.113

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.113

IGT and IFG. Time for revision?

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.113

Glucose tolerance and mortality: comparison of WHO and American Diabetic Association diagnostic criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.113

Lowering the criterion for impaired fasting glucose is in order

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.113

Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.113

Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.113

Predicting impaired glucose metabolism in women with polycystic ovary syndrome by decision tree modelling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.113

Predictors of abnormal glucose metabolism in women with polycystic ovary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.113

Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.113

Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.113

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.113

Prevalence of insulin resistance in the polycystic ovary syndrome using the homeostasis model assessment

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.113

Use of fasting blood to assess the prevalence of insulin resistance in women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.113

PCOS according to the Rotterdam consensus criteria: Change in prevalence among WHO-II anovulation and association with metabolic factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.113

Criteria for Defining Polycystic Ovary Syndrome as a Predominantly Hyperandrogenic Syndrome: An Androgen Excess Society Guideline

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.113

Prediction of diabetes using ADA or WHO criteria in post-menopausal women: a 10-year follow-up study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.113

Impact of degree of obesity on surrogate estimates of insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.113

Prospective study of C-reactive protein in relation to the development of diabetes and metabolic syndrome in the Mexico City Diabetes Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.113

21 January 2018

Identifiers

DOI

10.1515/CCLM.2007.113

1 reference

1 November 2017

1 reference